Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.6016
-0.0233 (-3.73%)
At close: Jun 27, 2025, 4:00 PM
0.6000
-0.0016 (-0.27%)
After-hours: Jun 27, 2025, 6:57 PM EDT
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $5.68 million as of June 27, 2025. Its market cap has increased by 8.41% in one year.
Market Cap
5.68M
Enterprise Value
8.75M
1-Year Change
8.41%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $5.68M, a decrease of -83.89%. That is a compound annual growth rate of -39.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 6.14M | -27.32% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |